Search
for
Sort by
Research 121–150 of 220
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- S100A6: molecular function and biomarker role
- Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- PROTACs: A novel strategy for cancer drug discovery and development
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Long and short non-coding RNA and radiation response: a review
- Msi2 Maintains Quiescent State of Hair Follicle Stem Cells by Directly Repressing the Hh Signaling Pathway
- Poster Presentations
- Current Biomedical Applications of 3D-Printed Hydrogels
- Preclinical Challenges in Proton Minibeam Radiotherapy: Physics and Biomedical Aspects
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- The molecular pathogenesis of Trichilemmal carcinoma
- Systematic analysis of somatic mutations driving cancer: uncovering functional protein regions in disease development
- Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation
- Molecular characterization, expression and methylation status analysis of BMP4 gene in skin tissue of Liaoning cashmere goat during hair follicle cycle
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Extracellular Vesicles for Regenerative Medicine Applications
- Metformin and Malignant Tumors: Not Over the Hill
- Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Extracellular vesicles in age-related diseases: disease pathogenesis, intervention, and biomarker
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Bioengineered microneedles and nanomedicine as therapeutic platform for tissue regeneration
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Preclinical Development and Phase I Study of ZSYY001, a Polymeric Micellar Paclitaxel for Advanced Solid Tumor
- <i>IGF2BP2</i> and <i>IGFBP3</i> Genotypes, Haplotypes, and Genetic Models Studies in Polycystic Ovary Syndrome
- The mechanisms of MicroRNA 21 in premature ovarian insufficiency mice with mesenchymal stem cells transplantation